priavoid.com
  • Home
  • About us
    • Overview
    • Strategy
    • Management
    • Supervisory Board
    • Scientific Advisory Board
    • History
  • Drug Development
    • Therapeutic Focus
    • Technology
    • Pipeline
  • Investors and Media
    • News
    • Events
    • Partnering
    • Archive
  • Contact us
    • Careers
Seite wählen

Prof. Willbold´s interview with PharmaVentures

November 14th, 2017

Learn more
Düsseldorf-Jülich Symposium on Neurodegenera7ve Diseases 2017 Bildquelle: Fotolia

Prof. Dieter Willbold talks with Summer Park of PharmaVentures at Biotech and Money Investival, London in 2017.

News & Events:

Office establishment

Office establishment

6. März 2020
09th BIO.NRW Business Angel Congress

09th BIO.NRW Business Angel Congress

3. März 2020
BIO-EUROPE SPRING 2020

BIO-EUROPE SPRING 2020

3. März 2020
AD/PD 2020

AD/PD 2020

14. Februar 2020
BIO.NRW MEDICA-FORUM

BIO.NRW MEDICA-FORUM

3. Dezember 2019
Seed Investment

Seed Investment

6. Mai 2019
CEOs of Priavoid

CEOs of Priavoid

3. Mai 2019
Prof. Willbold´s interview with PharmaVentures

Prof. Willbold´s interview with PharmaVentures

23. Januar 2018
Science September 7th, 2017

Science September 7th, 2017

10. September 2017
Clinical trial with PRI-002

Clinical trial with PRI-002

31. Mai 2017
  • Home
  • Investors and Media
  • Legal Notice
  • Privacy Policy
  • Contact us
Copyright © 2019 Priavoid GmbH